{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:50Z","timestamp":1789519610682,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["56151"],"award-info":[{"award-number":["56151"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12026-022-09355-z","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T09:03:07Z","timestamp":1672736587000},"page":"451-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role of cytokines and T-bet, GATA3, ROR-\u03b3t, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-0384","authenticated-orcid":false,"given":"Burcin Aydin","family":"Ozgur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan Adin","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender","family":"Coskunpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Altunkanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Osman","family":"Gurol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Temel","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"Suppl 1","key":"9355_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.diabres.2005.03.003","volume":"68","author":"MT Malecki","year":"2005","unstructured":"Malecki MT. Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2005;68(Suppl 1):S10-21.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8 Suppl","key":"9355_CR2","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1902\/jop.2008.080246","volume":"79","author":"GL King","year":"2008","unstructured":"King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8 Suppl):1527\u201334.","journal-title":"J Periodontol"},{"issue":"5","key":"9355_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2337\/diabetes.54.5.1253","volume":"54","author":"MA Atkinson","year":"2005","unstructured":"Atkinson MA. ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can\u2019t we prevent or reverse this disease? Diabetes. 2005;54(5):1253\u201363.","journal-title":"Diabetes"},{"key":"9355_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d7163","volume":"343","author":"D Noble","year":"2011","unstructured":"Noble D, et al. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343: d7163.","journal-title":"BMJ"},{"issue":"1\u20133","key":"9355_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12026-009-8124-7","volume":"46","author":"X Cao","year":"2010","unstructured":"Cao X. Regulatory T cells and immune tolerance to tumors. Immunol Res. 2010;46(1\u20133):79\u201393.","journal-title":"Immunol Res"},{"issue":"5","key":"9355_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, et al. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775\u201387.","journal-title":"Cell"},{"issue":"2","key":"9355_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2567.2007.02557.x","volume":"121","author":"K Luopajarvi","year":"2007","unstructured":"Luopajarvi K, et al. Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes. Immunology. 2007;121(2):189\u201396.","journal-title":"Immunology"},{"issue":"4","key":"9355_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","volume":"75","author":"C Zhang","year":"2014","unstructured":"Zhang C, et al. The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Hum Immunol. 2014;75(4):289\u201396.","journal-title":"Hum Immunol"},{"issue":"2","key":"9355_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3892\/mmr.2014.2778","volume":"11","author":"L Li","year":"2015","unstructured":"Li L, et al. Skewed T-helper (Th)1\/2- and Th17\/T regulatory cell balances in patients with renal cell carcinoma. Mol Med Rep. 2015;11(2):947\u201353.","journal-title":"Mol Med Rep"},{"key":"9355_CR10","volume":"2014","author":"A Vojdani","year":"2014","unstructured":"Vojdani A, Pollard KM, Campbell AW. Environmental triggers and autoimmunity. Autoimmune Dis. 2014;2014: 798029.","journal-title":"Autoimmune Dis"},{"issue":"2","key":"9355_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00109-011-0816-5","volume":"90","author":"C Zeng","year":"2012","unstructured":"Zeng C, et al. The imbalance of Th17\/Th1\/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl). 2012;90(2):175\u201386.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"9355_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jbspin.2008.04.005","volume":"75","author":"MC Boissier","year":"2008","unstructured":"Boissier MC, et al. Shifting the imbalance from Th1\/Th2 to Th17\/Treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine. 2008;75(4):373\u20135.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"9355_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yjmcc.2008.04.003","volume":"45","author":"X Cheng","year":"2008","unstructured":"Cheng X, et al. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-\/-) mice through modulation of Th1\/Th2 balance. J Mol Cell Cardiol. 2008;45(2):168\u201375.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"9355_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11302-013-9396-x","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock G. Purinergic signalling in endocrine organs. Purinergic Signal. 2014;10(1):189\u2013231.","journal-title":"Purinergic Signal"},{"issue":"1","key":"9355_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.18388\/abp.2014_853","volume":"62","author":"M Cieslak","year":"2015","unstructured":"Cieslak M, Wojtczak A, Cieslak M. Role of pro-inflammatory cytokines of pancreatic islets and prospects of elaboration of new methods for the diabetes treatment. Acta Biochim Pol. 2015;62(1):15\u201321.","journal-title":"Acta Biochim Pol"},{"issue":"3","key":"9355_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007724","volume":"2","author":"JI Odegaard","year":"2012","unstructured":"Odegaard JI, Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med. 2012;2(3): a007724.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9355_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06826.x","volume":"1281","author":"LE Padgett","year":"2013","unstructured":"Padgett LE, et al. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci. 2013;1281:16\u201335.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"9355_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"TL van Belle","year":"2011","unstructured":"van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011;91(1):79\u2013118.","journal-title":"Physiol Rev"},{"issue":"2","key":"9355_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","volume":"155","author":"A Willcox","year":"2009","unstructured":"Willcox A, et al. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155(2):173\u201381.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"9355_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","volume":"67","author":"JC Pickup","year":"2000","unstructured":"Pickup JC, et al. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67(3):291\u2013300.","journal-title":"Life Sci"},{"key":"9355_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/515136","volume":"2010","author":"C Wang","year":"2010","unstructured":"Wang C, Guan Y, Yang J. Cytokines in the progression of pancreatic beta-cell dysfunction. Int J Endocrinol. 2010;2010: 515136.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"9355_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00005-012-0210-1","volume":"61","author":"V Wieser","year":"2013","unstructured":"Wieser V, Moschen AR, Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz). 2013;61(2):119\u201325.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"9355_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2337\/diab.42.1.44","volume":"42","author":"SW Christianson","year":"1993","unstructured":"Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid\/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 1993;42(1):44\u201355.","journal-title":"Diabetes"},{"issue":"1","key":"9355_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4049\/jimmunol.146.1.85","volume":"146","author":"C Thivolet","year":"1991","unstructured":"Thivolet C, et al. CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J Immunol. 1991;146(1):85\u20138.","journal-title":"J Immunol"},{"issue":"9","key":"9355_CR25","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/eji.1830220931","volume":"22","author":"H Yagi","year":"1992","unstructured":"Yagi H, et al. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol. 1992;22(9):2387\u201393.","journal-title":"Eur J Immunol"},{"key":"9355_CR26","unstructured":"Bellemore, S.M., The role of IL-22 produced by Th17 cells in type 1 diabetes, in Microbiology and Immunology 2013, The University of Western Ontario."},{"issue":"1","key":"9355_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","volume":"164","author":"AM Thornton","year":"2000","unstructured":"Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164(1):183\u201390.","journal-title":"J Immunol"},{"key":"9355_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/2251-6581-13-46","volume":"13","author":"JT Bazzaz","year":"2014","unstructured":"Bazzaz JT, et al. TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications. J Diabetes Metab Disord. 2014;13:46.","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"9355_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.4049\/jimmunol.1301742","volume":"192","author":"CR Li","year":"2014","unstructured":"Li CR, Mueller EE, Bradley LM. Islet antigen-specific Th17 cells can induce TNF-alpha-dependent autoimmune diabetes. J Immunol. 2014;192(4):1425\u201332.","journal-title":"J Immunol"},{"issue":"2","key":"9355_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-014-8440-0","volume":"47","author":"T Tan","year":"2014","unstructured":"Tan T, et al. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. Clin Rev Allergy Immunol. 2014;47(2):234\u201343.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"9355_CR31","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.4049\/jimmunol.1000788","volume":"185","author":"J Honkanen","year":"2010","unstructured":"Honkanen J, et al. IL-17 immunity in human type 1 diabetes. J Immunol. 2010;185(3):1959\u201367.","journal-title":"J Immunol"},{"key":"9355_CR32","first-page":"29","volume":"222","author":"N Kikodze","year":"2013","unstructured":"Kikodze N, et al. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes. Georgian Med News. 2013;222:29\u201335.","journal-title":"Georgian Med News"},{"issue":"21","key":"9355_CR33","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1073\/pnas.0900621106","volume":"106","author":"M Ayyoub","year":"2009","unstructured":"Ayyoub M, et al. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A. 2009;106(21):8635\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"9355_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079858","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu X, et al. Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS ONE. 2013;8(11): e79858.","journal-title":"PLoS ONE"},{"issue":"7","key":"9355_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/08820139.2016.1197243","volume":"45","author":"R Baharlou","year":"2016","unstructured":"Baharlou R, et al. Elevated levels of T-helper 17-associated cytokines in diabetes type I patients: indicators for following the course of disease. Immunol Invest. 2016;45(7):641\u201351.","journal-title":"Immunol Invest"},{"issue":"4","key":"9355_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00005-012-0177-y","volume":"60","author":"A Szypowska","year":"2012","unstructured":"Szypowska A, et al. Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five. Arch Immunol Ther Exp (Warsz). 2012;60(4):307\u201313.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"9355_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2249.2008.03810.x","volume":"154","author":"JM Lawson","year":"2008","unstructured":"Lawson JM, et al. Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin Exp Immunol. 2008;154(3):353\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"9355_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.18388\/abp.2009_2469","volume":"56","author":"W Luczynski","year":"2009","unstructured":"Luczynski W, et al. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes. Acta Biochim Pol. 2009;56(2):361\u201370.","journal-title":"Acta Biochim Pol"},{"issue":"12","key":"9355_CR39","doi-asserted-by":"publisher","first-page":"7308","DOI":"10.4049\/jimmunol.173.12.7308","volume":"173","author":"RK Gregg","year":"2004","unstructured":"Gregg RK, et al. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol. 2004;173(12):7308\u201316.","journal-title":"J Immunol"},{"issue":"6","key":"9355_CR40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.4103\/2230-8210.102998","volume":"16","author":"AM Zahran","year":"2012","unstructured":"Zahran AM, Elsayh KI, Metwalley KA. Regulatory T cells in children with recently diagnosed type 1 diabetes. Indian J Endocrinol Metab. 2012;16(6):952\u20137.","journal-title":"Indian J Endocrinol Metab"},{"key":"9355_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2015.04.009","volume":"98","author":"B ElEssawy","year":"2015","unstructured":"ElEssawy B, Li XC. Type 1 diabetes and T regulatory cells. Pharmacol Res. 2015;98:22\u201330.","journal-title":"Pharmacol Res"},{"issue":"4","key":"9355_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/sji.12418","volume":"83","author":"S Hamari","year":"2016","unstructured":"Hamari S, et al. Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children. Scand J Immunol. 2016;83(4):279\u201387.","journal-title":"Scand J Immunol"},{"issue":"2","key":"9355_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.diabres.2011.07.027","volume":"94","author":"Y Li","year":"2011","unstructured":"Li Y, et al. Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults. Diabetes Res Clin Pract. 2011;94(2):242\u20138.","journal-title":"Diabetes Res Clin Pract"},{"key":"9355_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/JIR.S3547","volume":"1","author":"J Wallden","year":"2008","unstructured":"Wallden J, et al. No evidence for activation of T(H)1 or T(H)17 pathways in US peripheral blood mononuclear cells from children with beta-cell autoimmunity or T1D. J Inflamm Res. 2008;1:11\u20137.","journal-title":"J Inflamm Res"},{"issue":"1","key":"9355_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s125-002-8241-7","volume":"45","author":"LL Field","year":"2002","unstructured":"Field LL. Genetic linkage and association studies of Type I diabetes: challenges and rewards. Diabetologia. 2002;45(1):21\u201335.","journal-title":"Diabetologia"},{"issue":"5","key":"9355_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.gene.6363875","volume":"3","author":"F Pociot","year":"2002","unstructured":"Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun. 2002;3(5):235\u201349.","journal-title":"Genes Immun"},{"issue":"3","key":"9355_CR47","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.clim.2011.02.016","volume":"139","author":"D Han","year":"2011","unstructured":"Han D, et al. Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes. Clin Immunol. 2011;139(3):290\u2013301.","journal-title":"Clin Immunol"},{"issue":"8","key":"9355_CR48","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/db10-1643","volume":"60","author":"S Arif","year":"2011","unstructured":"Arif S, et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes. 2011;60(8):2112\u20139.","journal-title":"Diabetes"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09355-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-022-09355-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09355-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:48:56Z","timestamp":1684208936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-022-09355-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9355"],"URL":"https:\/\/doi.org\/10.1007\/s12026-022-09355-z","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}